Dennis E. Kyle majored in Biology at the University of Tennessee at Chattanooga (BA, 1979) and completed a PhD in Zoology at Clemson University (1984). Following a postdoctoral position at the University of Georgia, he began a 21 year association with the Walter Reed Army Institute of Research (WRAIR). During this time he led key efforts with the US Army’s Drug and Vaccine Development Programs, eventually serving as Deputy Director of the Division of Experimental Therapeutics at WRAIR. During this period he also served as the Chief, Department of Immunology and Parasitology at the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand (1991-94) and was a senior scientist in the malaria drug program at the Australian Army Malaria Institute (AMI) from 2002-04. His research interests include elucidation of mechanisms of antimalarial drug resistance and discovery of new anti-parasitic drugs for diverse disease including malaria, visceral leishmaniasis, and primary amoebic meningoencephalitis.
Dr. Kyle has more than 175 publications in the peer-reviewed scientific literature, serves on peer review panels for the National Institutes of Health and chaired the Genomics and Discovery Research Steering Committee and the Compound Evaluation Network for the World Health Organization. He is a Fellow of the American Society for Tropical Medicine and Hygiene and the American Association for the Advancement of Science. His lab is supported by research funding from National Institutes of Health, the Bill and Melinda Gates Foundation, and Medicines for Malaria Venture.
For more details about research in the Kyle Lab visit the lab web page.